Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre‐treatment neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta‐analysis and trial sequential analysis
Pierluigi Mariani, Diana Russo, Marco Maisto, et al.
Journal of Oral Pathology and Medicine (2021) Vol. 51, Iss. 1, pp. 39-51
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Efficacy of the Geriatric Nutritional Risk Index for Predicting Overall Survival in Patients with Head and Neck Cancer: A Meta-Analysis
Ching-Yi Yiu, Chien‐Cheng Liu, Jheng‐Yan Wu, et al.
Nutrients (2023) Vol. 15, Iss. 20, pp. 4348-4348
Open Access | Times Cited: 30
Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Akihiro Sakai, Hiroaki Iijima, Koji Ebisumoto, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2021-2021
Open Access | Times Cited: 18
The Immune Cells in the Development of Oral Squamous Cell Carcinoma
Vito Carlo Alberto Caponio, Khrystyna Zhurakivska, Lorenzo Lo Muzio, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3779-3779
Open Access | Times Cited: 14
The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma
Konstantinos Seretis, Konstantinos Sfaelos, Elena Boptsi, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1044-1044
Open Access | Times Cited: 5
Tumor–Stroma Ratio in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis
Gennaro Musella, Martina Coppini, Fábio França Vieira e Silva, et al.
Oral Diseases (2025)
Open Access
Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis
Mario Dioguardi, Stefania Cantore, Diego Sovereto, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1269-1269
Open Access | Times Cited: 16
Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors
Akihiro Sakai, Koji Ebisumoto, Hiroaki Iijima, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis
Fábio França Vieira e Silva, Vito Carlo Alberto Caponio, Mario Pérez‐Sayáns, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104202-104202
Open Access | Times Cited: 10
Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma
Lorenzo Fernandes Moça Trevisani, Isabelle Fernandes Kulcsar, Marco Aurélio Vamondes Kulcsar, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5245-5245
Open Access | Times Cited: 9
Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis
Jan A. Stratmann, Radha Timalsina, Akin Atmaca, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 15
Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer
Qiu-Yue Han, Xia Zhang, Jiangang Zhang, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109371-109371
Closed Access | Times Cited: 13
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma
Jiao Zhou, Sheng Wei, Xiumei Guo, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis
Yiwei Sun, Yuxiao Li, Wenjuan Zhou, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma
Rosa Alessia Battista, Giacomo Maria Pini, A Finco, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2759-2759
Open Access | Times Cited: 2
Neutrophil-to-lymphocyte ratio versus platelet-to-lymphocyte ratio in predicting clinical outcomes in acute methanol poisoning
Hanan M. Abdelwahab, Ola Elsayed Nafea, Radwa Elsherif, et al.
Human & Experimental Toxicology (2022) Vol. 41
Open Access | Times Cited: 9
[Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].
Junqi Su, Xiaoying Wang, Zhiqiang Sun
PubMed (2024) Vol. 56, Iss. 1, pp. 120-130
Closed Access | Times Cited: 1
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer
Ping‐Chih Hsu, Bing-Chen Wu, Chin‐Chou Wang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 474-474
Open Access | Times Cited: 1
What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?
Shogo Kikuta, Yushi Abe, Kiyosato Hino, et al.
Journal of Stomatology Oral and Maxillofacial Surgery (2024) Vol. 125, Iss. 4, pp. 101961-101961
Closed Access | Times Cited: 1
Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies
Yingying Zhang, Fang‐Hua Liu, Yali Wang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104525-104525
Closed Access | Times Cited: 1
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas
Kedar Kirtane, Maie A. St. John, Harry E Fuentes, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7259-7259
Open Access | Times Cited: 7
THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS
Diana Russo, Mariani Pierluigi, MENDITTI DARDO, et al.
Journal of Evidence Based Dental Practice (2023) Vol. 23, Iss. 4, pp. 101898-101898
Closed Access | Times Cited: 3
Dietary Polyphenols against Oxidative Stress in Head and Neck Cancer: What's New, What's Next
Andrea Ballini, Khrystyna Zhurakivska, Giuseppe Troiano, et al.
Journal of Cancer (2023) Vol. 15, Iss. 2, pp. 293-308
Open Access | Times Cited: 3
Predictive Value of Combined Peripheral Inflammatory Markers in Patients with Head and Neck Cancers
Hiroyuki Iuchi, Junichiro Ohori, Megumi Haraguchi, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Investigating sarcopenia, physical activity, and inflammation biomarkers in newly diagnosed oral cancer patients undergoing curative treatment: A prospective longitudinal study
Chun-Hou Huang, Tai‐Chu Peng, Yu‐Fu Chou, et al.
Asia-Pacific Journal of Oncology Nursing (2023) Vol. 10, Iss. 8, pp. 100261-100261
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top